Navigation Links
Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment
Date:8/17/2008

SYDNEY, Australia, Aug. 17 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced that the first pivotal Phase 3 clinical trial of Bronchitol for the treatment of cystic fibrosis has completed enrolment.

The first efficacy data from the trial is expected to be available during the first half of 2009. The trial commenced its dosing phase in April 2007, reached its initial recruitment target of 250 subjects in June 2008 and closed today with 325 subjects enrolled. Recruitment was extended to cater for a lower numbers of patients than anticipated entering the study on rhDNASE.

The trial is a double blind, comparator controlled, randomised study comparing 400 mg of Bronchitol twice a day to control. The trial includes a 26-week efficacy and safety component, followed by a 26 week open-label Bronchitol safety extension.

The primary efficacy end-point is change from baseline in FEV1 (forced expiratory volume in one second) after 26 weeks.

Pharmaxis Chief Executive Officer Alan Robertson said: "It is rewarding to reach this milestone in bringing Bronchitol to the marketplace. The study has enrolled well, and we look forward to the results helping to shape cystic fibrosis clinical practice in the future."

Pharmaxis has received Orphan Drug Designation and fast track status from the U.S. Food and Drug Administration and Orphan Drug Designation from the European Medicines Agency for Bronchitol in cystic fibrosis.

Bronchitol is designed to hydrate the airway surface of the lungs, improve lung hygiene and promote normal lung clearance.

Approximately 75,000 people in the major pharmaceutical markets are affected with cystic fibrosis and no products have been approved to improve lung hydration.

To find out more about Pharmaxis, go to http://www.pharmaxis.com.au .

Forward-Looking Statements

The statements contained in thi
'/>"/>

SOURCE Pharmaxis Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Bronchitol Cystic Fibrosis Dose Trial Results Positive
2. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
3. Pharmaxis Establishes Named Patient Program for Bronchitol
4. Pharmaxis Long-Term Safety Study of Bronchitol Completes
5. Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172
6. U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)
7. Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus
8. Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex(TM) Phase 3 Stroke Trials
9. Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma
10. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
11. Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 27, 2015 As per the new ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 ... billion in 2014, growing at a CAGR of 13.2% from ... 2021. The global bionics market is growing primarily ... is leading to paralysis or amputation of body parts. In ...
(Date:7/27/2015)... , July 27, 2015 The Physician-Patient Alliance ... PPAHS posted its first blog on July 27, ... heart beat? ". This post featured what ... attack outside of a grocery store in Goodhue, ... 96-minute CPR marathon involving 20 others, who took turns pumping ...
(Date:7/27/2015)... MENLO PARK, Calif. , July 27, ... DMPI) ("DelMar" and the "Company"), a biopharmaceutical company ... in new orphan drug indications, today announced that ... investors for a registered direct placement ("Placement") of ... million common stock purchase warrants for aggregate purchases ...
Breaking Medicine Technology:Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 2Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 4Physician-Patient Alliance for Health & Safety Turns 4 Years Old 2DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 2DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 3
(Date:7/28/2015)... ... ... Advanced Fertility Center of Texas (AFCT) has hosted the EMBCOL office since the ... Laboratory Director at AFCT, was one of the founders of EMBCOL and served as ... credited with the discovery of intra-cytoplasmic sperm injection (ICSI) , which has revolutionized ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... Intellitec Solutions ... Accounting Today’s annual ranking of Value Added Resellers of ERP Software is a look ... are presented with. This honor represents the second such award in 2015 for Intellitec ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Nurses across all ... time, up to 57 million Americans may need mental health services (SAMHSA, 2013) and ... Psychiatric-mental health RNs are one of the largest workforces who provide care ...
(Date:7/28/2015)... CA (PRWEB) , ... July 28, 2015 , ... ... 2015 NoSQL Now! Conference, August 18-20 at the McHenry Convention Center in ... and exhibiting in booth #104. , Scientel’s presentation on Multi-Modeling and the industry’s first ...
(Date:7/28/2015)... ... ... President of the Veterans Fund of the United States, managing the United Veteran Beacon House ... a campaign to help homeless Veterans by giving them “A hand up – not a ... the UVBH assists and supports Vets through the Veterans Fund of the United States ...
Breaking Medicine News(10 mins):Health News:Advanced Fertility Center of Texas Is Proud to Announce That Our Lab Director Has Been Re-elected as The American College of Embryology President 2Health News:Intellitec Solutions Named by Accounting Today as Top 100 Value Added Reseller 2Health News:American Psychiatric Nurses Association Transitions in Practice Certificate Program to Improve Mental Health Care Through Continuing Nursing Education 2Health News:American Psychiatric Nurses Association Transitions in Practice Certificate Program to Improve Mental Health Care Through Continuing Nursing Education 3Health News:American Psychiatric Nurses Association Transitions in Practice Certificate Program to Improve Mental Health Care Through Continuing Nursing Education 4Health News:Scientel Selected to Present at 2015 NoSQLNow! Conference, San Jose August 18-20 2Health News:Scientel Selected to Present at 2015 NoSQLNow! Conference, San Jose August 18-20 3Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 2Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 3
... An estimated 2.7 million people in the United States ... as chronic olfactory dysfunction. // Head trauma, viral infection, ... or normal aging can cause chronic olfactory dysfunction. ... or smell, you know how different you feel. Some ...
... results when too much uric acid builds up in the ... to meat and yes // to low-fat dairy if you ... rich in dairy products and low in beef, pork, lamb ... lies in the high purine content of many meats and ...
... researchers have found that certain hormones in the body ... of cardiovascular // events and death in people with ... levels well below the current standards used to diagnose ... failure. They tested the participants’ blood looking for specific ...
... United States, is linked to obesity and lack of exercise. It ... properly to metabolize food, especially sugar. Type-I or juvenile diabetes is ... ,In a recent study of 14,600 people, it was ... had nearly an 80 percent lowered risk, while men who drank ...
... According to latest research unhealthy ways of expressing anger ... way of //expressing anger." According to past research, stress ... who do not practice healthy anger or stress management ... nearly 160 adolescents, ages 14 to 17, for three ...
... the population but account for nearly 20 percent of ... risk factor for // suicide in the elderly. New ... in depressed elderly patients. ,Researchers from Cornell ... elderly patients with depression. Some patients were assigned “care ...
Cached Medicine News:
This design features a solid red iris....
This camouflaging lens features the solid black stripes of the lightning fast African zebra, on a white iris background....
Sphere Introducer...
Reusable cannula with .90 mm (20 g) shaft, tapering to .30 mm (30 g). Angled 125 3 mm from tip and flattened for easy insertion into the subretinal space....
Medicine Products: